Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s New GST Tax A Game Changer For Pharma But Challenges Ahead

Executive Summary

India’s ambitious new Goods and Services Tax, aimed at turning the country into a single common market, will be a ‘game-changer’ with a mix of impacts for the pharma industry and the rest of the economy, but the rollout involves overcoming considerable logistical challenges.

Advertisement

Related Content

Bumpy Ride Awaits Indian Firms In 2018 (And Then There’s Amazon)

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel